Normal view MARC view ISBD view

Use of depot antipsychotic medications for medication nonadherence in schizophrenia. [electronic resource]

By:

West, Joyce C

Contributor(s):

Producer: 20081230Description: 995-1001 p. digitalISSN:

0586-7614

Subject(s):

Online resources:

Available from publisher's website

In: Schizophrenia bulletin vol. 34

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

3901 The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity.
by Patel, Sachin
3902 Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats.
by Rueda-Orozco, Pavel E
3903 Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
by Ryan, Duncan
3904 Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.
by Cisneros, José Antonio
3905 Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.
by Ho, J M
3906 In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells.
by Andrianova, E L
3907 The molecular basis of the cooperation between EGF, FGF and eCB receptors in the regulation of neural stem cell function.
by Sütterlin, Philipp
3908 Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.
by Marini, Ida
3909 Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution.
by Schalk-Hihi, Céline
3910 The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects.
by Erdozain, Amaia M
3911 Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.
by Orman, Eric S
3912 Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.
by De Carvalho, Cristiane Ribeiro
3913 Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.
by Patel, Reesha R
3914 Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia.
by Clarke, David J
3915 Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model.
by Wilkerson, Jenny L
3916 Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses.
by Wang, Y
3917 Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
by Páez, Juan A
3918 Impact of maternal western diet-induced obesity on offspring mortality and peripheral endocannabinoid system in mice.
by Perez, Pedro A
3919 Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase.
by Carnevale, Lauren N
3920 Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment.
by Gianessi, Carol A